Skip to Content
Merck
CN
  • Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.

Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.

The Journal of the Association of Physicians of India (2012-05-24)
Lokender Kumar, Rajnish Gupta, M M Puri, Anand Jaiswal, Srinath, Amit Murar, Digamber Behera
ABSTRACT

A case of isoniazid induced gynecomastia is being reported in an 18-year old male, who received a re-treatment regimen for the relapse of pulmonary tuberculosis (TB). At the end of two months of the treatment, the patient developed a painless unilateral gynecomastia, which completely disappeared after a month of the cessation of isoniazid. A review of literature on isoniazid induced gynecomastia is discussed.

MATERIALS
Product Number
Brand
Product Description

Isoniazid, European Pharmacopoeia (EP) Reference Standard
Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Supelco
Isoniazid, Vetec, reagent grade, 98%